To further prove the additional immune stimulatory function of LMP1-shRNA2, we generated the NPC-LMP1 antigen-specific CTLs from NPC-LMP1 cells under the treatment of different sequence-specific shRNAs targeting LMP1 or control gene in vitro. The gene discussed is PDLIM7; the disease is nasopharyngeal carcinoma.